PT1054868E - Novas piridino arilpiperazinas substitidas uteis no tratamento de hiperplasia prostatica benigna - Google Patents

Novas piridino arilpiperazinas substitidas uteis no tratamento de hiperplasia prostatica benigna

Info

Publication number
PT1054868E
PT1054868E PT99934281T PT99934281T PT1054868E PT 1054868 E PT1054868 E PT 1054868E PT 99934281 T PT99934281 T PT 99934281T PT 99934281 T PT99934281 T PT 99934281T PT 1054868 E PT1054868 E PT 1054868E
Authority
PT
Portugal
Prior art keywords
arilpiperazines
treatment
benign prostatic
prostatic hyperplasia
new pyridine
Prior art date
Application number
PT99934281T
Other languages
English (en)
Portuguese (pt)
Inventor
William V Murray
Catherine Prouty
Gee-Hong Kuo
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of PT1054868E publication Critical patent/PT1054868E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
PT99934281T 1998-02-20 1999-02-19 Novas piridino arilpiperazinas substitidas uteis no tratamento de hiperplasia prostatica benigna PT1054868E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7532198P 1998-02-20 1998-02-20

Publications (1)

Publication Number Publication Date
PT1054868E true PT1054868E (pt) 2004-01-30

Family

ID=22124955

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99934281T PT1054868E (pt) 1998-02-20 1999-02-19 Novas piridino arilpiperazinas substitidas uteis no tratamento de hiperplasia prostatica benigna

Country Status (23)

Country Link
US (1) US6218396B1 (enExample)
EP (1) EP1054868B1 (enExample)
JP (1) JP2002503724A (enExample)
KR (1) KR100591028B1 (enExample)
CN (1) CN1121390C (enExample)
AR (1) AR014626A1 (enExample)
AT (1) ATE250580T1 (enExample)
AU (1) AU766398B2 (enExample)
BR (1) BR9909647A (enExample)
CZ (1) CZ294136B6 (enExample)
DE (1) DE69911582T2 (enExample)
DK (1) DK1054868T3 (enExample)
ES (1) ES2209468T3 (enExample)
HU (1) HUP0100781A3 (enExample)
IL (2) IL137954A0 (enExample)
NO (1) NO317103B1 (enExample)
NZ (1) NZ506462A (enExample)
PL (1) PL342339A1 (enExample)
PT (1) PT1054868E (enExample)
TR (1) TR200003220T2 (enExample)
TW (1) TW565555B (enExample)
WO (1) WO1999042448A1 (enExample)
ZA (1) ZA991315B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1269807C (zh) * 1997-05-12 2006-08-16 奥索-麦克尼尔药品公司 可用于治疗良性前列腺肥大的芳基取代哌嗪
ES2282279T3 (es) 2000-08-08 2007-10-16 Ortho-Mcneil Pharmaceutical, Inc. No-imidazol ariloxipiperidina como ligandos del receptor h3.
JP3878178B2 (ja) * 2001-12-28 2007-02-07 武田薬品工業株式会社 排尿障害予防治療剤
USD545208S1 (en) 2006-09-27 2007-06-26 001 Corporation Perfume bottle and cap
EP2077262A4 (en) * 2006-10-23 2011-12-28 Takeda Pharmaceutical IMINOPYRIDINE DERIVATIVE AND USE THEREOF
MX2010011652A (es) * 2008-04-23 2010-12-06 Takeda Pharmaceutical Derivados de iminopiridina y uso de los mismos.
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用
CN108530391B (zh) * 2018-05-17 2022-05-17 袁牧 一种酰胺类芳基哌嗪衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2027898A6 (es) * 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
AU8130298A (en) * 1997-07-15 1999-02-10 Sankyo Company Limited Piperazine derivatives

Also Published As

Publication number Publication date
JP2002503724A (ja) 2002-02-05
CN1121390C (zh) 2003-09-17
EP1054868A1 (en) 2000-11-29
AU766398B2 (en) 2003-10-16
IL137954A0 (en) 2001-10-31
DE69911582D1 (de) 2003-10-30
US6218396B1 (en) 2001-04-17
CZ20003044A3 (cs) 2001-04-11
NO20004141L (no) 2000-10-19
HUP0100781A2 (hu) 2001-08-28
ZA991315B (en) 2000-11-20
AR014626A1 (es) 2001-03-28
TW565555B (en) 2003-12-11
WO1999042448A1 (en) 1999-08-26
TR200003220T2 (tr) 2001-04-20
HK1030776A1 (en) 2001-05-18
CN1291188A (zh) 2001-04-11
IL137954A (en) 2007-06-03
DK1054868T3 (da) 2003-12-22
KR20010041115A (ko) 2001-05-15
NZ506462A (en) 2003-07-25
CZ294136B6 (cs) 2004-10-13
ES2209468T3 (es) 2004-06-16
BR9909647A (pt) 2000-11-21
ATE250580T1 (de) 2003-10-15
NO20004141D0 (no) 2000-08-18
AU3302599A (en) 1999-09-06
KR100591028B1 (ko) 2006-06-22
PL342339A1 (en) 2001-06-04
EP1054868B1 (en) 2003-09-24
HUP0100781A3 (en) 2002-12-28
DE69911582T2 (de) 2005-09-15
NO317103B1 (no) 2004-08-09

Similar Documents

Publication Publication Date Title
NO993396L (no) Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
DE60023982D1 (de) System zur Behandlung von benigner Prostatahyperplasie
BR9608651A (pt) Método para o tratamento de hiperplasia prostática benigna com terapia térmica
ATE300597T1 (de) Behandlung von geweben
PT1077940E (pt) 4-fenilpiperidinas novas para o tratamento de dermatoses pruriginosas
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
NO992069D0 (no) Konjugater som kan anvendes ved behandling av prostatakreft
DE69832300D1 (de) Schrank und wandteil
PT1054868E (pt) Novas piridino arilpiperazinas substitidas uteis no tratamento de hiperplasia prostatica benigna
IL120302A0 (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
NO995518L (no) Arylsubstituerte piperaziner brukbare ved behandling av benign prostatisk hyperplasi
NO20002804L (no) Konjugater som kan anvendes ved behandling av prostatakreft
DE69939166D1 (de) Wasserenthärtungs- und waschmittelzusammensetzungen
BR9608912A (pt) Agonistas de meletonina para o tratamento de hiperplasia prostática benigna
NO20004142L (no) Ftalimidoarylpiperaziner som <alfa> 1A reseptorantagonister anvendelige ved behandling av benign prostatahyperplasi
GB9602903D0 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
PT943733E (pt) Fixacao elatica de aparelhos de via, nomeadamente contra-agulhas
EP1435913A4 (en) METHOD OF TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER BENCH PROSTATIC PATHOLOGIES
GB9810895D0 (en) Combination therapy for the treatment of benign prostatic hyperplasia
AU2002232403A1 (en) Del-1 and benign prostatic hyperplasia
AU2002300904A1 (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
UA25491A (uk) Спосіб профілактики стриктур уретри при адеhомектомії передміхурової залози
SE9600419D0 (sv) Varmvattensbehandling